One major limitation of this study is that, despite integrating in silico analyses, immunohistochemistry, and in vitro validation, in vivo studies were not conducted to confirm the functional role of PNP–HER-2 interactions in BC progression and metastasis. Here, ERBB2 is linked to breast cancer.